• Generic Name
• Item
• Area
• Certification
• Note
• Structuer
• API
• Inquiry

• Macitentan tablet 10mg
• Formulation
• Pulmonary arterial hypertension
• USA-ANDA No. 211026 Tentative Approval, China-CYHS1900599 Launched
• 
• Macitentan
• Inquiry

• Selexipag tablet
• Formulation
• Pulmonary arterial hypertension
• ready for PV
• Selexipag
• Inquiry

• Vortioxetine tablet 5mg
• Formulation
• Antidepressant
• China-CDE Registration 5mg CYHS2400133 10mg CYHS2400134
• 
• Vortioxetine
• Inquiry

• Vortioxetine tablet 10mg
• Formulation
• antidepressant
• China-CDE Registration 5mg CYHS2400133 10mg CYHS2400134
• 
• Vortioxetine HBr
• Inquiry

• Vortioxetine tablet 20mg
• Formulation
• antidepressant
• China-CDE Registration 5mg CYHS2400133 10mg CYHS2400134
• 
• Vortioxetine HBr
• Inquiry

• N-Propylsulfamide sodium salt
• other
• Macitentan
• Inquiry

• Macitentan;N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
• other
• 
• Inquiry

• Rapamycin;Sirolimus;23,27-Epoxy-3h-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
• other
• 
• Inquiry

• 4-(4-Nitrophenyl)morpholin-3-one
• other
• 
• Rivaroxaban
• Inquiry

• Selexipag;2-[4-[(5,6-Diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide
• other
• Inquiry

• 4-(Isopropylamino)butanol
• other
• Selexipag
• Inquiry

• 4-[(5,6-Diphenylpyrazin-2-yl)-propan-2-ylamino]butan-1-ol
• other
• Selexipag
• Inquiry